A current review of juvenile pemphigus vulgaris: Analysis of data on clinical outcomes

American Journal of Clinical Dermatology

Volumn 11, Issue 1, 2010, Pages 21-33

  Asarch, Adam ^a   Gürcan, Hakan M ^b   Ahmed, A Razzaque ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW ENGLAND BAPTIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOMALATE; AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DAPSONE; DEXAMETHASONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RITUXIMAB; STAPHYLOCOCCUS PROTEIN A;

ACNE; AVASCULAR NECROSIS; CATARACT; CELLULITIS; CONDUCT DISORDER; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; GASTROINTESTINAL CANDIDIASIS; GASTROINTESTINAL INFECTION; GROWTH DISORDER; GROWTH RETARDATION; HUMAN; HYPERTENSION; IMMUNOADSORPTION; IMMUNOPATHOLOGY; INFECTION; JUVENILE PEMPHIGUS VULGARIS; LONG TERM CARE; MENSTRUAL IRREGULARITY; MONOTHERAPY; MOON FACE; MULTIPLE CYCLE TREATMENT; OBESITY; ONSET AGE; OSTEOPENIA; PATHOPHYSIOLOGY; PEMPHIGUS VULGARIS; PLASMAPHERESIS; PRIORITY JOURNAL; RACE DIFFERENCE; RELAPSE; REVIEW; SIDE EFFECT; SUPERINFECTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; WEIGHT GAIN;

ADOLESCENT; AUTOANTIBODIES; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; PEMPHIGUS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949358467     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11310380-000000000-00000     Document Type: Review

References (42)

1. Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005 Jul 2-8; 366 (9479): 61-73
2. Ahmed AR, Salm M. Juvenile pemphigus. J Am Acad Dermatol 1983 Jun; 8 (6): 799-807
3. Sillevis Smitt JH. Pemphigus vulgaris in childhood: clinical features, treatment, and prognosis. Pediatr Dermatol 1985 Mar; 2 (3): 185-190
4. Elias PM, Jarratt M, Zalitis IE, et al. Childhood pemphigus vulgaris. N Engl J Med 1972 Oct 12; 287 (15): 758-760
5. Menter MA, Bell AA, Wells RS. Pemphigus vulgaris in a boy aged thirteen. Guys Hosp Rep 1973; 122 (1-2): 123-127
6. Wrancz AE. Combined treatment with steroids and imuran of pemphigus vulgaris in a 15-year-old girl [in Polish]. Przegl Dermatol 1975; 62: 551-553
7. Harrington I, Sneddon IB, Walker AE. Pemphigus vulgaris in a 15-year-old girl. Acta Derm Venereol 1978; 58 (3): 277-279
8. Sodaify M, Vollum DI. Pemphigus vulgaris in adolescence. Clin Exp Dermatol 1979 Jun; 4 (2): 205-207
9. Laskaris G, Sklavounou A, Bovopoulou O. Juvenile pemphigus vulgaris. Oral Surg Oral Med Oral Pathol 1981 Apr; 51 (4): 415-420
10. Hempstead RW, Marks Jr JG. Pediatric pemphigus vulgaris: treatment with topical adrenal steroids. Arch Dermatol 1984 Jul; 120 (7): 962-963
11. Lynde CW, OngleyRC, Rigg JM. Juvenile pemphigus vulgaris. Arch Dermatol 1984 Aug; 120 (8): 1098-1099
12. Jacyk WK, Dyer RB. Juvenile pemphigus vulgaris: a case report. S Afr Med J 1987 Mar 7; 71 (5): 325
13. David M, Zaidenbaum M, Sandbank M. Juvenile pemphigus vulgaris: a 4-to 19-year follow-up of 4 patients. Dermatologica 1988; 177 (3): 165-169
14. Graff-Lonnevig V, Kaaman T. Juvenile pemphigus vulgaris. Acta Paediatr Scand 1991 Feb; 80 (2): 262-265
15. Kanwar AJ, Kaur S. Pemphigus in children. Int J Dermatol 1991 May; 30 (5): 343-346
16. Gorsky M, Raviv M, Raviv E. Pemphigus vulgaris in adolescence: a case presentation and review of the literature. Oral Surg Oral Med Oral Pathol 1994 Jun; 77 (6): 620-622
17. Kanwar AJ, Dhar S, Kaur S. Further experience with pemphigus in children. Pediatr Dermatol 1994 Jun; 11 (2): 107-111
18. Wananukul S, Pongprasit P. Childhood pemphigus. Int J Dermatol 1999 Jan; 38 (1): 29-35
19. Schmidt E, Herzog S, Brocker EB, et al. Long-standing remission of re-calcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab. Br J Dermatol 2005 Aug; 153 (2): 449-451
20. Yazganoglu KD, Baykal C, Kucukoglu R. Childhood pemphigus vulgaris: five cases in 16 years. J Dermatol 2006 Dec; 33 (12): 846-849
21. Mamelak AJ, Eid MP, Cohen BA, et al. Rituximab therapy in severe juvenile pemphigus vulgaris. Cutis 2007 Oct; 80 (4): 335-340
22. Asarch A, Ahmed AR. Treatment of juvenile pemphigus vulgaris with in-travenous immunoglobulin therapy. Pediatr Dermatol 2009 Mar-Apr; 26 (2): 197-202
23. Ahmed AR, Dahl MV. Consensus statement on the use of intravenous im-munoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol 2003 Aug; 139 (8): 1051-1059
24. Chams-Davatchi C, Valikhani M, Daneshpazhooh M, et al. Pemphigus: anal-ysis of 1209 cases. Int J Dermatol 2005 Jun; 44 (6): 470-476
25. Esmaili N, Chams-Davatchi C, Valikhani M, et al. Pemphigus vulgaris in Iran: a clinical study of 140 cases. Int J Dermatol 2007 Nov; 46 (11): 1166-1170
26. Ljubojevic S, Lipozencic J, Brenner S, et al. Pemphigus vulgaris: a review of treatment over a 19-year period. J Eur Acad Dermatol Venereol 2002 Nov; 16 (6): 599-603
27. Lever WF, White H. Treatment of pemphigus with corticosteroids: results obtained in 46 patients over a period of 11 years. Arch Dermatol 1963 Jan; 87: 12-26
28. Robinson JC, Lozada-Nur F, Frieden I. Oral pemphigus vulgaris: a review of the literature andareportonthe managementof12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 Oct; 84 (4): 349-355
29. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus: an update. Arch Dermatol 1996 Feb; 132 (2): 203-212
30. Diab M, Bechtel M, Coloe J, et al. Treatment of refractory pemphigus erythematosus with rituximab. Int J Dermatol 2008 Dec; 47 (12): 1317-1318
31. Daoud YJ, Amin KG. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases. Int Immunopharmacol 2006 Apr; 6 (4): 600-606
32. Yokota S, Mori M, Imagawa T, et al. Proposal for juvenile idiopathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists (2007). Mod Rheumatol 2007; 17 (5): 353-363
33. Compeyrot-Lacassagne S, Feldman BM. Inflammatory myopathies in chil-dren. Rheum Dis Clin North Am 2007 Aug; 33 (3): 525-53, vii
34. Fisler RE, Liang MG, Fuhlbrigge RC, et al. Aggressive management of juve-nile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002 Oct; 47 (4): 505-511
35. Macdermott EJ, Adams A, Lehman TJ. Systemic lupus erythematosus in children: current and emerging therapies. Lupus 2007; 16 (8): 677-683
36. Brunner HI, Gladman DD, Ibanez D, et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008 Feb; 58 (2): 556-562
37. Kone-Paut I, Piram M, Guillaume S, et al. Lupus in adolescence. Lupus 2007; 16 (8): 606-612
38. Mintzer IJ, Rubin Z. Pemphigus vulgaris in athirteen-year-old girl. N Y State J Med 1955 Jul 1; 55 (13): 1903-1907
39. Jordon RE, Ihrig JJ, Perry HO. Childhood pemphigus vulgaris: report of a case. Arch Dermatol 1969 Feb; 99 (2): 176-179
40. Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976 Jul; 112 (7): 962-970
41. Bjarnason B, Flosadottir E. Childhood, neonatal, and stillborn pemphigus vulgaris. Int J Dermatol 1999 Sep; 38 (9): 680-688
42. Harman KE, Albert S, Black MM. Guidelines for the management of pem-phigus vulgaris. Br J Dermatol 2003 Nov; 149 (5): 926-937